Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :14667095
Publication Date : //

Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus.


The aim of the study was to assess the relationship between ischemic cerebrovascular accidents (ICVAs), that is, transient ischemic attack (TIA) or stroke, and left-sided heart valve abnormalities (LHVAs) in patients with systemic lupus erythematosus (SLE). In total, 71 consecutive SLE patients were studied. At baseline, history, clinical and laboratory evaluations, as well as trans-thoracic echocardiography (TTE) were performed. From the original population, so patients were followed up for a mean time of 5.80 +/- 1.53 years. After a mean period of 5.39 +/- 1.42 years; 40 patients underwent a repeat TTE. Previous ICVA history was present at baseline in 16 patients (22.5%). Of these, 13 (81.2%) had evidence of LHVAs on TTE. Previous ICVAs were significantly associated to diagnosis of secondary anti-phospholipid syndrome (SAPS), positivity for anti-cardiolipin antibodies (aCl), and LHVAs. Multivariate analysis confirmed the correlation between previous ICVAs and LHVAs. LHVAs were not more commonly observed in patients with SAPS compared to patients without SAPS. At the end of follow-up, irrespective of any differences in antithrombotic treatment, ICVAs had occurred in 13 patients. During follow-up, ICVAs had recurred in seven patients, while a first event TIA occurred in one patient. Multivariate analysis confirmed the relationship between ICVAs and LHVAs, and a trend towards a positive correlation of the former with SAPS. This study demonstrates that LHVAs represent a compelling risk factor for the development of ICVAs in SLE patients. Conversely, SAPS and aCl positivity, although associated with ICVAs, did not clearly correlate with LHVAs in our study. These results provide insight on the pathogenesis of ICVAs and may give clues on the potential efficacy of preventive/therapeutic strategies in different SLE subpopulations.

Authors : Morelli S , Bernardo M L , Viganego F , Sgreccia A , De Marzio P , Conti F , Priori R , Valesini G ,

Related products :

Catalog number Product name Quantity
E02S0264 Rat systemic lupus erythematosus 96 Tests/kit
E01S0264 Human systemic lupus erythematosus 96 Tests/kit
E03S0264 Mouse systemic lupus erythematosus 96 Tests/kit
E11S0264 Bovine systemic lupus erythematosus 96 Tests/kit
E05S0264 Guinea systemic lupus erythematosus 96 Tests/kit
E08S0264 Canine systemic lupus erythematosus 96 Tests/kit
E04S0264 Rabbit systemic lupus erythematosus 96 Tests/kit
E02S0264 Rat anti-systemic lupus erythematosus 96 Tests/kit
E07S0264 Porcine systemic lupus erythematosus 96 Tests/kit
E06S0264 Goat systemic lupus erythematosus 96 Tests/kit
E12411841 Rat systemic lupus erythematosus(SLE) ELISA Kit 1
E13S0264 Anserine systemic lupus erythematosus 96 Tests/kit
SLE1H2_R2S Systemic Lupus Erythematosus (SLE),SLE1H2:2 SignArrays
E01S0264 Human Anti-systemic lupus erythematosus 96 Tests/kit
E13751685 Rabbit systemic lupus erythematosus(SLE) ELISA Kit 1
SLE1H1_F24S Systemic Lupus Erythematosus (SLE),SLE1H1:24 SignArrays
SLE1H1_F12S Systemic Lupus Erythematosus (SLE),SLE1H1:12 SignArrays
201-12-0468 Human systemic lupus erythematosus(SLE)ELISA Kit 96T
SLE1H1_F8S Systemic Lupus Erythematosus (SLE),SLE1H1:8 SignArrays
E13S0264 Anserine anti - systemic lupus erythematosus 96 Tests/kit
E12531731 Mouse systemic lupus erythematosus(SLE) ELISA Kit 1
CK-E10410 Human systemic lupus erythematosus,SLE ELISA Kit 96T
CSB-E09695h Human systemic lupus erythematosus,SLE ELISA Kit 96T
E15861685 Porcine systemic lupus erythematosus(SLE) ELISA Kit
E03S0264 Mouse anti-systemic lupus erythematosus 96 Tests/kit


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur